Suppr超能文献

抗肿瘤磺酰脲抑制培养的HeLa细胞分泌到培养基中的NADH氧化酶。

Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.

作者信息

Morré D J, Wilkinson F E, Kim C, Cho N, Lawrence J, Morré D M, McClure D

机构信息

Department of Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA.

出版信息

Biochim Biophys Acta. 1996 Apr 26;1280(2):197-206. doi: 10.1016/0005-2736(95)00290-1.

Abstract

Conditioned culture media of HeLa S cells contain a soluble NADH oxidase activity inhibited by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N' -(4-chlorophenyl)urea (LY181984) similar to that associated with the outer surface of the plasma membrane. This activity was absent from media in which cells had not been grown and was present in conditioned culture media from which cells had been removed by centrifugation both for serum-containing and serum-free media. The Km with respect to NADH and response to thiol reagents were similar to those of the corresponding activity of the plasma membrane of HeLa cells. The conditioned HeLa culture media bound [3H]LY181984 with high affinity. Both antitumor sulfonylurea-inhibited and -resistant forms of the NADH oxidase were isolated by free-flow electrophoresis. The antitumor sulfonylurea-inhibited activity was purified to apparent homogeneity and was identified with a 33.5 kDa protein with an isoelectric point of about pH 4.5. The 33.5 kDa protein from conditioned HeLa culture medium both bound [3H]LY181984 and retained an LY181984-inhibited NADH oxidase activity. A polyclonal antisera was raised in rabbits to the purified 33.5 kDa constituent from conditioned HeLa culture medium. The antisera blocked the activity of the LY181984-inhibited NADH oxidase activity, immunoprecipitated the activity and reacted with a 33.5 kDa protein on Western blots while preimmune sera did not. Also inhibited and immunoprecipitated was NADH oxidase activity from HeLa plasma membranes. The findings are consistent with the 33.5 kDa drug-inhibited NADH oxidase activity of the culture media being a shed form of the corresponding native 34 kDa antitumor sulfonylurea-inhibited NADH oxidase activity of the HeLa cell plasma membrane.

摘要

HeLa S细胞的条件培养基含有一种可溶性NADH氧化酶活性,该活性被抗肿瘤磺酰脲类药物N-(4-甲基苯基磺酰基)-N'-(4-氯苯基)脲(LY181984)抑制,类似于与质膜外表面相关的活性。未生长过细胞的培养基中不存在这种活性,而在通过离心去除细胞的条件培养基中存在,无论是含血清还是无血清培养基。相对于NADH的米氏常数和对硫醇试剂的反应与HeLa细胞质膜相应活性的相似。条件HeLa培养基以高亲和力结合[3H]LY181984。通过自由流动电泳分离出抗肿瘤磺酰脲类药物抑制和抗性形式的NADH氧化酶。将抗肿瘤磺酰脲类药物抑制的活性纯化至表观均一,并鉴定为一种等电点约为pH 4.5的33.5 kDa蛋白质。来自条件HeLa培养基的33.5 kDa蛋白质既结合[3H]LY181984,又保留LY181984抑制的NADH氧化酶活性。用来自条件HeLa培养基的纯化33.5 kDa成分在兔中制备多克隆抗血清。该抗血清阻断LY181984抑制的NADH氧化酶活性,免疫沉淀该活性,并在蛋白质印迹上与33.5 kDa蛋白质反应,而免疫前血清则不反应。HeLa质膜的NADH氧化酶活性也被抑制和免疫沉淀。这些发现与培养基中33.5 kDa药物抑制的NADH氧化酶活性是HeLa细胞质膜相应天然34 kDa抗肿瘤磺酰脲类药物抑制的NADH氧化酶活性的脱落形式一致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验